Insider Transactions in Q4 2023 at Annovis Bio, Inc. (ANVS)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2023
|
Henry Hagopian Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
824
+31.12%
|
$4,944
$6.07 P/Share
|
|
Nov 20
2023
|
Maria Luisa Maccecchini President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
41,186
+3.61%
|
$247,116
$6.07 P/Share
|
|
Nov 20
2023
|
Mark K. White Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+3.17%
|
$12,000
$6.07 P/Share
|
|
Nov 20
2023
|
Michael B Hoffman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
164,745
+42.35%
|
$988,470
$6.07 P/Share
|
|
Nov 20
2023
|
Reid Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
824
+9.2%
|
$4,944
$6.07 P/Share
|
|
Nov 20
2023
|
Claudine Bruck Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+11.67%
|
$6,000
$6.07 P/Share
|